Dr Urban Kiernan and Dr Stephen Naylor

The complexity and uniqueness of human metabolism and physiology in the past decade has been highlighted and dissected. Arguments have been made to...

By Dr Lorna C. Ewart, et al.

Changing demands in global healthcare over the past 15 years have led to greater complexity and spiralling costs in drug development. The average p...

By Dr Anton Fliri, et al.

Part 2: Emergent intelligence, a new paradigm for drug discovery.

By Dr Yasmina Noubia Abdiche

The innate ability of antibodies to bind their targets with high affinity and exquisite specificity is leveraged in the discovery of therapeutic an...

By Dr Frank F. Craig

Microfluidic platforms that harness picodroplet technology (picolitre volume aqueous droplets in stabilised oil emulsions) are unlocking the potent...

Dr Satnam Surae

A review of the current approaches to data management and application within the drug development and research setting, highlighting major critical...

Helen Stewart-Miller and Dr Richard Massey

Mass spectrometry (MS) has long been a valuable tool for drug discovery, and steady advances in its capabilities and performance have generated pow...

Professor Anthony Coates and Dr Yanmin Hu

Antibiotic resistance is at a crossroad. In the world today, deaths in low income countries from Antimicrobial Resistance (AMR) are predicted to ri...

Mary Kay Bates

Cell therapies are poised to play a pivotal role in the development of precision and personalised medicines that will transform healthcare for mill...

Pioneering Surgical Guidance System from Endomag Wins Institute of Physics’ Business Innovation Award

Agreement gives Teleflex access to Arcis’ nucleic acid sample preparation technology

Distributor will supply Chirascan circular dichroism spectrometers and SX stopped-flow spectrometers to Ireland and Northern Ireland

Prestigious business award granted in recognition of expert services in cell and gene therapy

ROSLINCT and REPROCELL awarded £1.2 million from Innovate UK for clinical-grade stem cell production

Royalty bearing license agreement to commercialise a product incorporating the Affimer technology

Dates: 9-10 October 2018
Venue: London, UK

Dates: 3-7 November 2018
Venue: San Diego, USA

Dates: 4-8 November 2018
Venue: Washington DC, USA